BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24625436)

  • 1. Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes.
    Galvaing G; Tardy MM; Cassagnes L; Da Costa V; Chadeyras JB; Naamee A; Bailly P; Filaire E; Pereira B; Filaire M
    Ann Thorac Surg; 2014 May; 97(5):1708-13. PubMed ID: 24625436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer.
    Spaggiari L; D' Aiuto M; Veronesi G; Pelosi G; de Pas T; Catalano G; de Braud F
    Ann Thorac Surg; 2005 Jan; 79(1):234-40. PubMed ID: 15620949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
    Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
    Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcome of combined pulmonary and atrial resection for lung cancer.
    Bobbio A; Carbognani P; Grapeggia M; Rusca M; Sartori F; Bobbio P; Rea F
    Thorac Cardiovasc Surg; 2004 Jun; 52(3):180-2. PubMed ID: 15192780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
    Perentes J; Bopp S; Krueger T; Gonzalez M; Jayet PY; Lovis A; Matzinger O; Ruffieux C; Ris HB; Letovanec I; Peters S
    Ann Thorac Surg; 2012 Dec; 94(6):1815-22. PubMed ID: 23103000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery on extracorporeal circulation in early and advanced non-small cell lung cancer.
    Kauffmann M; Krüger T; Aebert H
    Thorac Cardiovasc Surg; 2013 Mar; 61(2):103-8. PubMed ID: 23212162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer.
    Daly BD; Ebright MI; Walkey AJ; Fernando HC; Zaner KS; Morelli DM; Kachnic LA
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1392-7. PubMed ID: 21281948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer.
    Yang CJ; Shah SA; Lin BK; VanDusen KW; Chan DY; Tan WD; Ranney DN; Cox ML; D'Amico TA; Berry MF
    Ann Thorac Surg; 2019 Apr; 107(4):1074-1081. PubMed ID: 30448482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
    Kim AW; Liptay MJ; Bonomi P; Warren WH; Basu S; Farlow EC; Faber LP
    Ann Thorac Surg; 2011 Jul; 92(1):233-41; discussion 241-3. PubMed ID: 21620372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. En bloc resection of non-small-cell lung cancer invading the spine.
    Schirren J; Dönges T; Melzer M; Schönmayr R; Eberlein M; Bölükbas S
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):647-54. PubMed ID: 21334220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgery for lung cancer invading the great vessels and left atrium].
    Iwasaki A
    Nihon Geka Gakkai Zasshi; 2013 Jul; 114(4):176-81. PubMed ID: 23898704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary sleeve resection in locally advanced lung cancer using cryopreserved allograft for pulmonary artery replacement.
    Berthet JP; Boada M; Paradela M; Molins L; Matecki S; Marty-Ané CH; Gómez-Caro A
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1191-7. PubMed ID: 23953718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
    Mansour Z; Kochetkova EA; Santelmo N; Ducrocq X; Quoix E; Wihlm JM; Massard G
    Ann Thorac Surg; 2008 Jul; 86(1):228-33. PubMed ID: 18573428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.